-
About
Mass General- Hospital Overview
- Why Mass General
- In the Local & Global Community
- Massachusetts General Physicians Organization
- Multimedia
- News & Events
- Support Mass General
- Conditions
& Treatments- View All Conditions & Treatments
- View by Medical Category:
- Centers
& Services- Care Centers
- Departments
- Anesthesia, Critical Care
& Pain Medicine - Dermatology
- Emergency Medicine
- Imaging
- Medicine
- Molecular Biology
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Anesthesia, Critical Care
- Facilities & Amenities
- Patient & Family Services
- Research
- View All Research Centers & Labs
- Research at Mass General
- Research News & Events
-
Clinical
Trials - Education
& Training- View All Fellowships, Residencies & CME
- Specialized Education & Training
- Education & Training Calendar
- Career
Opportunities
Steven Jay Isakoff, MD, PhD
- Phone: 617-726-6500
- Departments
- Hematology/Oncology
- Department of Medicine
Specialties
- Cancer Center
- Breast Cancer
- Clinical Interests
- Novel and targeted therapies for breast cancer treatment
- Breast cancer
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, PhD, New York University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Dana-Farber Cancer Institute
- Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
- Gender
- Male
- Patient Age Group
- Adult
- Accepting New Patients
- Yes
Publications
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, Stubbs H, McDermott U, Settleman J, Kwak EL, Clark JW, Isakoff SJ, Sequist LV, Engelman JA, Lynch TJ, Haber DA, Louis DN, Ellisen LW, Borger DR, Iafrate AJ.
EMBO Mol Med. 2010 May;2(5):146-58.PMID: 20432502
EMBO Mol Med. 2010 May;2(5):146-58.PMID: 20432502
Triple-negative breast cancer: role of specific chemotherapy agents.Isakoff SJ. Cancer J. 2010 Jan-Feb;16(1):53-61. Review.
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS. Cancer Res. 2005 Dec 1;65(23):10992-1000.
Innovations in Breast Cancer Treatment
As part of the multidisciplinary approach to breast cancer treatment, Mass General Cancer Center patients receive care from an integrated team of pathologists, radiologists, and medical, surgical, and radiation oncologists.
Hematology/Oncology
55 Fruit Street
Boston, MA 02114-2696
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-6500
Fax: 617-724-1079
- © 2013 Massachusetts General Hospital
- 55 Fruit Street, Boston, MA 02114
- Maps & Directions
- 617-726-2000
- TDD: 617-724-8800
